1353867-93-2

1353867-93-2 structure
1353867-93-2 structure

Name Triclabendazole-D3
Synonyms MFCD20264917
Triclabendazole-(methyl-d3)
1H-Benzimidazole, 5-chloro-6-(2,3-dichlorophenoxy)-2-(methyl-d3-thio)-
5-Chloro-6-(2,3-dichlorophenoxy)-2-[(2H3)methylsulfanyl]-1H-benzimidazole
5-Chloro-6-(2,3-dichlorophenoxy)-2-(methyl-d3-thio)-1H-benzimidazole
Description Triclabendazole-d3 is the deuterium labeled 4-Methoxybenzylamine[1].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Density 1.6±0.1 g/cm3
Boiling Point 495.9±55.0 °C at 760 mmHg
Molecular Formula C14H6D3Cl3N2OS
Molecular Weight 362.68
Flash Point 253.7±31.5 °C
Exact Mass 360.968933
LogP 5.97
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.724
RIDADR NONH for all modes of transport